The Current Landscape of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer: Emerging Treatment Paradigms and Future Directions Angel QinShirish Gadgeel Review Article 31 August 2017 Pages: 709 - 718
Antibody–Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments Aiko NagayamaLeif W. EllisenAditya Bardia Review Article 08 November 2017 Pages: 719 - 739
Targeting FGFR in Squamous Cell Carcinoma of the Lung Neda Hashemi-SadraeiNasser Hanna Review Article 06 July 2017 Pages: 741 - 755
The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors Fabiola Amair-PinedoIgnacio MatosJaume Capdevila Review Article 15 November 2017 Pages: 757 - 774
A Multi-Arm Phase I Study of the PI3K/mTOR Inhibitors PF-04691502 and Gedatolisib (PF-05212384) plus Irinotecan or the MEK Inhibitor PD-0325901 in Advanced Cancer Zev A. WainbergMaria AlsinaJosep Tabernero Original Research Article Open access 24 October 2017 Pages: 775 - 785
CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer Yu SunakawaAkihito TsujiWataru Ichikawa Original Research Article 24 October 2017 Pages: 787 - 794
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma Giovan Giuseppe Di CostanzoAndrea Casadei GardiniRaffaella Tortora Original Research Article 03 August 2017 Pages: 795 - 803
Comparative Safety of Targeted Therapies for Metastatic Colorectal Cancer between Elderly and Younger Patients: a Study Using the International Pharmacovigilance Database Amandine GouverneurPauline ClarazPernelle Noize Original Research Article 11 October 2017 Pages: 805 - 814
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib Anke E. M. van ErpMelissa H. S. Hillebrandt-RoeffenYvonne M. H. Versleijen-Jonkers Original Research Article Open access 24 October 2017 Pages: 815 - 826
Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase Xiaohui ChangLin ZhouYang Xiang Short Communication 08 August 2017 Pages: 827 - 832
Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study) Jean-Bernard AuliacIsabelle MonnetChristos Chouaid Short Communication 31 July 2017 Pages: 833 - 838
Comment on: “Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study)” Arnaud Uguen Letter to the Editor 28 October 2017 Pages: 839 - 840
Author’s Reply to Arnaud Uguen: “Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study)” Jean-Bernard AuliacChristos Chouaid Letter to the Editor 28 October 2017 Pages: 841 - 842
